Background: Patients with COVID-19 are at a high risk for the development of venous thromboembolic disease . Alveolar capillary microthrombi appear to be 9x more prevalent in patients with COVID-19 compared to H1N1. As a result, enhanced-dose anticoagulation ...
Background: Medicine by press release has been an unfortunate reality of the COVID-19 pandemic. This is not the standard many physicians would use for medical decision making, but one many of us have had to face; what do I do ...
Early reports have shown that COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute VTE and exactly how to treat it is an evolving area. Limited data suggest pulmonary microvascular thrombosis may play a role in ...
Background: In elderly patients on chronic anticoagulation (i.e. warfarin and clopidogrel), falls have been shown to increase the incidence of intracranial hemorrhage (ICH) versus those not on anticoagulation (8.0% vs 5.3%). Mortality in those with ICH on anticoagulation is also higher ...
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
